What is the best salvage therapy for patients with Helicobacter pylori infection?

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 5, Issue 11, 2008, Pages 608-609

  Fuccio, Lorenzo ^a   Zagari, Rocco Maurizio ^a   Bazzoli, Franco ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; FURAZOLIDONE; LEVOFLOXACIN; PROTON PUMP INHIBITOR; RIFABUTIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; DIARRHEA; DIZZINESS; DRUG CHOICE; DRUG EFFICACY; DRUG FEVER; DRUG MEGADOSE; DRUG TREATMENT FAILURE; ERADICATION THERAPY; GLOSSITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MULTIDRUG RESISTANCE; MYALGIA; NAUSEA; PRACTICE GUIDELINE; PRIORITY JOURNAL; SALVAGE THERAPY; TASTE DISORDER; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT PLANNING;

ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HUMANS; PROTON PUMP INHIBITORS; SALVAGE THERAPY; TREATMENT FAILURE;

EID: 55749097772     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep1256     Document Type: Article

References (18)

1. Gisbert JP et al. (2008) Empirical rescue therapy after Helicobacter pylori treatment failure: A 1 0-year-single-centre study of 500 patients. Aliment Pharmacol Ther 27: 346-354
2. Malfertheiner P et al. (2007) Current concepts in the management of Helicobacter pylori infection: The Maastricht III Consensus Report. Gut 56: 772-781
3. Bazzoli F et al. (1998). Evaluation of short low-dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double-blind, controlled study. Aliment Pharmacol Ther 12: 439-445
4. Neri M et al. (2003) Role of antibiotic sensitivity testing before first-line Helicobacter pylori eradication treatments. Aliment Pharmacol Ther 18: 821-827
5. Romano M et al. (2003) Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori. Clin Gastroenterol Hepatol 1: 273-278
6. Toracchio S et al. (2000). Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. Aliment Pharmacol Ther 14: 1639-1643
7. Lamouliatte H et al. (2003) Second-line treatment for failure to eradicate Helicobacter pylori: A randomized trial comparing four treatment strategies. Aliment Pharmacol Ther 18: 791-797
8. Miwa H et al. (2003) Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection? Aliment Pharmacol Ther 17: 1545-1551
9. Gomollon F et al. (2000) Third line treatment for Helicobacter pylori: A prospective, culture-guided study in peptic ulcer patients. Aliment Pharmacol Ther 14: 1335-1338
10. Cammarota G et al. (2004) High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection. Aliment Pharmacol Ther 19: 789-795
11. Fischbach LA et al. (2004) Meta-analysis: The efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies. Aliment Pharmacol Ther 20: 1071-1082
12. Megraud F (2004) H. pylori antibiotic resistance: Prevalence, importance and advances in testing. Gut 53: 1374-1384
13. Gisbert JP et al. (2006) Third-line rescue therapy with levofloxacin after two H. pylori treatment failures. Am J Gastroenterol 101: 243-247
14. Zullo A et al. (2003). A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication. Dig Liver Dis 35: 232-236
15. Perna F et al. (2007) Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: Role of bacterial resistance. Dig Liver Dis 39: 1001-1005
16. Carothers JJ et al. (2007) The relationship between previous fluoroquinolone use and levofloxacin resistance in Helicobacter pylori infection. Clin Infect Dis 44: 5-8
17. Gisbert JP et al. (2006) Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures. Aliment Pharmacol Ther 24: 1469-1474
18. Fakheri H et al. (2001) Clarithromycin versus furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate. Aliment Pharmacol Ther 15: 411-416